Entering text into the input field will update the search result below

Health Canada approves Sanofi's Sarclisa combination for multiple myeloma

Oct. 13, 2021 6:44 AM ETSanofi (SNY) StockBy: SA News Team

Doctor in blue gloves reads about Multiple myeloma.

designer491/iStock via Getty Images

  • Sanofi Canada (NASDAQ:SNY) announces that Health Canada has approved SARCLISA in combination with carfilzomib and dexamethasone (Kd) for the treatment of adult patients with relapsed or refractory multiple myeloma who have received 1 to 3 prior lines

Recommended For You

More Trending News

About SNY Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
SNY--
Sanofi